Status:
COMPLETED
Targeting Obesity With the Probiotic Lactiplantibacillus Plantarum IMC 510 (PRO-Weight-Control Study)
Lead Sponsor:
Azienda Ospedaliero-Universitaria Careggi
Conditions:
Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
In recent decades, the prevalence of obesity has reached epidemic proportions, with the number of overweight or obese individuals continuing to increase worldwide. Advances in recent research have all...
Detailed Description
Background Obesity is a multifactorial disease characterized by a chronic imbalance between energy intake and energy expenditure. Risk factors for weight excess are genetic, metabolic, hormonal, psyc...
Eligibility Criteria
Inclusion
- Men and women 18-65 years of age
- Obesity (BMI \>30 kg/m2, class I, II, III) and overweight (BMI 25-29.9 kg/m2)
- Willingness to cooperate during the study and ability to follow guidelines
- Willingness to complete questionnaires and diaries associated with the study and to complete all clinical visits
- Willingness to discontinue functional foods and dietary supplements with probiotics, laxatives and body weight control substances
- Ability to provide informed consent
Exclusion
- Continued use of probiotics in the two months prior to treatment
- Use of other treatments (medications or nutritional programs) that affect body weight, food intake and/or energy expenditure
- Postmenopausal women
- Pregnant or lactating
- Enrolled in another obesity treatment program
Key Trial Info
Start Date :
January 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05358301
Start Date
January 7 2022
End Date
October 31 2022
Last Update
February 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unit of Clinical Nutrition, University Hospital of Careggi
Florence, Italy, 50134